uniQure NV (0EE0.L)

Healthcare | Medical Pharmaceuticals
Latest reporting period: 2025-09-30

Latest Quarter

2025-09-30

Revenue

$3.7M

Net Income

-$80.5M

Operating Margin

-1,379.0%

Free Cash Flow

-$186M

Debt / Assets

101.2%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for uniQure NV (0EE0.L).
Income Statement (Quarterly) 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue 3,701,000 5,262,000 1,567,000 5,221,000
Cost of Revenue 398,000 656,000 197,000 619,000
Gross Profit 3,303,000 4,606,000 1,370,000 4,602,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 19,438,000 13,500,000 10,908,000 9,403,000
Operating Expenses 54,338,000 48,471,000 40,701,000 50,430,000
Operating Income -51,035,000 -43,865,000 -39,331,000 -45,828,000
Interest Expense 16,721,000 15,591,000 15,109,000 14,876,000
Income Before Tax -71,903,000 -37,294,000 -43,141,000 -72,405,000
Income Tax Expense 8,626,000 425,000 496,000 856,000
Net Income -80,529,000 -37,719,000 -43,637,000 -73,261,000
Per Share
EPS -1.38 -0.69 -0.82 -1.50
EPS Diluted 0.00 0.00 0.00 0.00